SLC9A3R1 and ADRB2

  • Number of citations of the paper that reports this interaction (PMID 9560162)
  • 107
  • Data Source:
  • HPRD (in vivo, in vitro)

SLC9A3R1

ADRB2

Gene Name solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 adrenoceptor beta 2, surface
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 52 interactors: ABCC2 ABCC4 ADRB2 AKAP10 ATP6V1B1 ATP6V1E1 BCL10 CFTR CLCN3 CNGA2 CTNNB1 EGFR EZR GNA11 GNAQ GRK6 KCNJ1 LHCGR LPAR2 MSN NF2 NOS2 OPRK1 P2RY1 PAG1 PDGFRA PDGFRB PDZK1 PIK3CA PLCB1 PLCB2 PTEN PTH1R RDX RLBP1 SCN4A SLC22A11 SLC22A4 SLC22A5 SLC22A9 SLC26A3 SLC34A1 SLC4A8 SLC9A3 SLCO1A2 SLCO3A1 TBC1D10A TRPC4 TRPC5 YAP1 YES1 ZNF468 88 interactors: ADRB3 ADRBK1 AKAP12 AKAP5 ALDOA ARF4 ARHGAP5 ARHGDIA ARR3 ARRB1 ARRB2 CCKBR CD4 CD68 CD81 CD9 CEACAM1 CNN1 CSK EGLN3 EIF2B1 GMPR2 GNA11 GNA14 GNA15 GNAI2 GNAS GNAT2 GNB1 GNB2L1 GNG2 GNL3L GPR37 GPR56 GPRASP1 GPRC5B GRB2 GRIA3 GRK5 GRK6 HDAC6 HTR4 IL1B IL6R INSR KCNE1 KCNJ6 KCNJ9 KCTD13 MAPK8IP2 MCAM MDM2 NEDD4 NOS1 OPRD1 PLA2G2D PRKCD PTGER1 RAB27A RAB3A RAN RAP2C REL RGS10 RGS11 RGS17 RGS2 RGS20 RGS5 RGS8 RGS9 RHOD RNF41 SLC52A2 SLC9A3R1 SLC9A3R2 SNCG SRC STAT3 STAT4 TSG101 TSHR UCHL1 VAPA VDAC1 VDAC2 VEGFB WNK1
Entrez ID 9368 154
HPRD ID 05406 00187
Ensembl ID ENSG00000109062 ENSG00000169252
Uniprot IDs O14745 P07550
PDB IDs 1G9O 1GQ4 1GQ5 1I92 1SGH 2D10 2JXO 2KJD 2KRG 2M0T 2M0U 2M0V 2OZF 1GQ4 2R4R 2R4S 2RH1 3D4S 3KJ6 3NY8 3NY9 3NYA 3P0G 3PDS 3SN6 4GBR 4LDE 4LDL 4LDO
Enriched GO Terms of Interacting Partners?
Tagcloud ?
adipogenic  alters  amscs  chondrogenic  commitment  deacetylases  destabilizes  foxo1  grown  hdac  hdac1  hdac11  hydroxamic  hyper  interferes  lysate  manipulation  mechanistically  mesenchymal  multipotency  multipotent  nherf1  osteogenic  perturbation  pluripotent  saha  sirt7  suberoylanilide  uncommitted 
acting  adrenergic  agonists  approved  arrestin  arrestin2  asthma  beta2  copd  decreasing  fda  ikappabalpha  improving  indacaterol  inhaled  inhibits  internalization  invasiveness  laba  mediates  obstructive  pharmacological  precise  preventing  recognized  relieving  subsequently  transmembrane  ultra 
Tagcloud (Difference) ?
adipogenic  alters  amscs  chondrogenic  commitment  deacetylases  destabilizes  foxo1  grown  hdac  hdac1  hdac11  hydroxamic  hyper  interferes  lysate  manipulation  mechanistically  mesenchymal  multipotency  multipotent  nherf1  osteogenic  perturbation  pluripotent  saha  sirt7  suberoylanilide  uncommitted 
acting  adrenergic  agonists  approved  arrestin  arrestin2  asthma  beta2  copd  decreasing  fda  ikappabalpha  improving  indacaterol  inhaled  inhibits  internalization  invasiveness  laba  mediates  obstructive  pharmacological  precise  preventing  recognized  relieving  subsequently  transmembrane  ultra 
Tagcloud (Intersection) ?